Today, Amgen shared its 2025 third quarter earnings report. Amgen’s employees are united by our mission to serve patients. We harness the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller, and longer.
“We delivered strong volume growth this quarter, reflecting the demand for our medicines and the impact we’re having on patients worldwide. With disciplined investment and a pipeline of first-in-class medicines, we’re focused on expanding access, advancing innovation, and sustaining long-term growth,” said Bob Bradway, chairman and chief executive officer.
The infographic below provides more highlights about the company’s 2025 third quarter results.
Additional details can be found in the earnings press release. Please see forward-looking statements.
A webcast of the earnings call can be found on Amgen’s Investors page.
